Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Assets (2016)

Historic Return on Assets for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to 2.8%.

  • Tenax Therapeutics' Return on Assets fell 24600.0% to 2.8% in Q3 2017 from the same period last year, while for Sep 2017 it was 2.8%, marking a year-over-year decrease of 24600.0%. This contributed to the annual value of 2.57% for FY2013, which is 18500.0% up from last year.
  • Per Tenax Therapeutics' latest filing, its Return on Assets stood at 2.8% for Q3 2017, which was down 24600.0% from 2.38% recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Return on Assets ranged from a high of 30.69% in Q1 2013 and a low of 40.36% during Q2 2013
  • In the last 3 years, Tenax Therapeutics' Return on Assets had a median value of 2.04% in 2017 and averaged 2.61%.
  • Over the last 5 years, Tenax Therapeutics' Return on Assets had its largest YoY gain of 326300bps in 2013, and its largest YoY loss of -594200bps in 2013.
  • Over the past 3 years, Tenax Therapeutics' Return on Assets (Quarter) stood at 40.36% in 2013, then soared by 97bps to 1.05% in 2016, then crashed by -168bps to 2.8% in 2017.
  • Its Return on Assets was 2.8% in Q3 2017, compared to 2.38% in Q2 2017 and 2.04% in Q1 2017.